Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

R. Leclercq Clinical Microbiology and Infection

Molecular and phenotypic characterization of invasive group B streptococcus strains from infants in Norway 2006–2007 H. Bergseng, J.E. Afset, A. Radtke,

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

G. Cornaglia, A. Lönnroth, M. Struelens

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Gut bacterial microbiota and obesity

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii X. Vila-Farres, C. Garcia.

Migrant health—a cause for concern?

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,

Quinolone resistance among Shigella spp

R. Cantón Clinical Microbiology and Infection

Surveillance of Legionnaires’ disease in Austria

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

D.E. Low Clinical Microbiology and Infection

Vector control: a cornerstone in the malaria elimination campaign

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.

Sofie Arens, Jan Verhaegen, Ludo Verbist

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A

Prevalence of Streptococcus pneumoniae isolates bearing macrolide resistance genes in association with integrase genes of conjugative transposons in Japan

Elements of design: the knowledge on which we build

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Levofloxacin in the treatment of ventilator-associated pneumonia

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe Anna King, Julie Downes, Carl-Erik Nord, Ian.

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli W.

Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis S.R. Norrby, J. Quinn, M. Rangaraju,

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

An after-hours clinical liaison blood culture service—is it worth it?

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin G. Drusano Clinical Microbiology and Infection

Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Abstracts Clinical Microbiology and Infection

Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy R.E. Mendes, T. Spanu, L. Deshpande, M. Castanheira,

M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür

Modification of prescribers’ behavior: the Icelandic approach

B.A. Cunha Clinical Microbiology and Infection

European recommendations for antimicrobial resistance surveillance

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.

Impact of antibiotic restrictions: the patient's perspective

The future of diagnostic bacteriology

Presentation transcript:

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M. Castanheira, A.C. Gales, R.E. Mendes, R.N. Jones, H.S. Sader Clinical Microbiology and Infection Volume 10, Issue 7, Pages 645-651 (July 2004) DOI: 10.1111/j.1469-0691.2004.00872.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Rates of resistance of Streptococcus pneumoniae to penicillin and erythromycin according to country. Penicillin resistance (a) was divided into intermediate resistance (MIC of 0.12-1 mg/L) and high-level resistance (MIC ≥ 2 mg/L), while erythromycin resistance (b) was divided into mef phenotype (resistance to erythromycin and susceptibility to clindamycin) and erm phenotype (resistance to both erythromycin and clindamycin). Clinical Microbiology and Infection 2004 10, 645-651DOI: (10.1111/j.1469-0691.2004.00872.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Penicillin and erythromycin resistance rates according to the year of isolation. Clinical Microbiology and Infection 2004 10, 645-651DOI: (10.1111/j.1469-0691.2004.00872.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions